29 results
8-K
EX-10.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its
S-3/A
EX-99.1
BBLG
Bone Biologics Corp
17 Jan 24
Shelf registration (amended)
5:21pm
Adverse Effect. There is no pending, completed or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration, or legal
8-K
EX-10.1
no03zls1
20 Nov 23
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:46am
424B4
ik0k43
11 Oct 22
Prospectus supplement with pricing info
10:57am
424B5
ms6jxo jii
2 Nov 21
Prospectus supplement for primary offering
3:50pm
424B4
q4k4 dw6l
15 Oct 21
Prospectus supplement with pricing info
6:07am
424B4
nzs01jev
15 Oct 21
Prospectus supplement with pricing info
6:06am
8-K
EX-1.1
nbuatx3meisvhwgy7s
15 Oct 21
Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split
6:05am